Concentrix (NASDAQ:CNXC) Given New $38.00 Price Target at Barrington Research

Concentrix (NASDAQ:CNXC) had its price target decreased by analysts at Barrington Research from $62.00 to $38.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Barrington Research’s target price suggests a potential upside of 46.05% from the stock’s current price.

A number of other research analysts have also commented on the company. Canaccord Genuity Group cut their target price on Concentrix from $80.00 to $55.00 and set a “buy” rating for the company in a research note on Wednesday. Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Robert W. Baird dropped their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a research note on Wednesday. Finally, Weiss Ratings downgraded shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $48.50.

Concentrix Stock Performance

CNXC stock traded down $0.46 during trading on Wednesday, reaching $26.02. 924,504 shares of the stock were exchanged, compared to its average volume of 1,446,836. Concentrix has a twelve month low of $24.27 and a twelve month high of $66.00. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.67. The company has a market capitalization of $1.60 billion, a P/E ratio of -1.25, a price-to-earnings-growth ratio of 0.35 and a beta of 0.50. The stock has a 50 day simple moving average of $35.34 and a 200-day simple moving average of $40.33.

Concentrix (NASDAQ:CNXC) last posted its quarterly earnings results on Tuesday, March 24th. The company reported $2.61 EPS for the quarter, missing the consensus estimate of $2.64 by ($0.03). Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The firm had revenue of $2.50 billion during the quarter, compared to analyst estimates of $2.49 billion. During the same period last year, the company earned $2.79 EPS. The company’s revenue was up 5.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Concentrix will post 10.11 earnings per share for the current year.

Insider Buying and Selling

In other Concentrix news, CEO Christopher A. Caldwell bought 1,000 shares of the firm’s stock in a transaction dated Thursday, January 29th. The shares were bought at an average price of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the acquisition, the chief executive officer owned 362,075 shares of the company’s stock, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Concentrix

Hedge funds have recently added to or reduced their stakes in the stock. Hsbc Holdings PLC increased its position in Concentrix by 60.1% in the fourth quarter. Hsbc Holdings PLC now owns 59,134 shares of the company’s stock worth $2,459,000 after purchasing an additional 22,187 shares during the period. Corient Private Wealth LLC bought a new position in shares of Concentrix in the 4th quarter valued at about $289,000. Pacer Advisors Inc. grew its position in shares of Concentrix by 73.2% during the 4th quarter. Pacer Advisors Inc. now owns 16,099 shares of the company’s stock worth $669,000 after buying an additional 6,804 shares during the period. Invesco Ltd. raised its stake in shares of Concentrix by 16.3% during the fourth quarter. Invesco Ltd. now owns 478,790 shares of the company’s stock worth $19,908,000 after buying an additional 67,036 shares during the last quarter. Finally, SummitTX Capital L.P. lifted its holdings in Concentrix by 268.0% in the fourth quarter. SummitTX Capital L.P. now owns 45,780 shares of the company’s stock valued at $1,904,000 after buying an additional 33,340 shares during the period. Institutional investors own 90.34% of the company’s stock.

More Concentrix News

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Company maintained full‑year and Q2 guidance and highlighted AI / iX Suite wins and banking growth, signaling continued commercial momentum and predictable revenue outlook. GlobeNewswire Q1 Release
• Positive Sentiment: Board declared a $0.36 quarterly dividend (5.3% yield) payable May 5 (ex‑dividend Apr 24) and the company repurchased ~1M shares in Q1 with ~$396.6M left on the authorization — shareholder returns that can support the stock. Dividend & Repurchase Details
• Neutral Sentiment: Top‑line held up: revenue increased 5.4% year‑over‑year ($2.50B) and roughly in line with consensus — a stabilizing data point even as margins slipped. Revenue & Guidance
• Negative Sentiment: GAAP profitability declined sharply: net income fell ~69% and diluted EPS fell to $0.33 from $1.04 year‑ago; operating margin and adjusted EBITDA margin contracted materially — profitability weakness is the main driver of the sell‑off. Q1 Results
• Negative Sentiment: Cash flow concerns: operating cash flow was negative and adjusted free cash flow was a use in the quarter, which raises near‑term liquidity/coverage questions despite the company’s guidance and buyback room. Cash Flow & Financials
• Negative Sentiment: Analysts trimmed price targets: Canaccord cut its target (from $80 to $55) while keeping a Buy rating and Robert W. Baird lowered its target (from $52 to $40) but kept an Outperform — PT cuts reduce upside expectations and can pressure the share price. Benzinga: Canaccord Benzinga: Baird
• Negative Sentiment: Market skepticism / bear commentary: critical investor pieces question valuation and execution despite low multiples, adding to investor caution (example: Seeking Alpha note). Seeking Alpha: Why I’m Not Buying

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.